Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006

Clinical Pediatrics

Volumn 47, Issue 9, 2008, Pages 901-906

  Pichichero, Michael E ^a   Casey, Janet R ^a   Hoberman, Alejandro ^b   Schwartz, Richard ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c INOVA FAIRFAX HOSPITAL FOR CHILDREN   (United States)

Author keywords

Acute otitis media; Haemophilus influenzae; Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MALE; MORAXELLA CATARRHALIS; MYRINGOTOMY; OTALGIA; RECURRENT DISEASE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

ACUTE DISEASE; CHI-SQUARE DISTRIBUTION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL VACCINES; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; RECURRENCE; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 53249113241     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922808319966     Document Type: Article

References (19)

1. Casey JR, Pichichero ME Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004 ; 23: 824-828.
2. Block SL, Hedrick J., Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004 ; 23: 829-833.
3. Whitney CG, Farley MM, Hadler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003 ; 348: 1737-1746.
4. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004 ; 113 (3 Pt 1). 443-449.
5. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005 ; 54: 893-897.
6. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007 ; 297: 1784-1792.
7. Pelton SI, Huot H., Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 ; 26: 468-472.
8. Pichichero ME, Casey JR Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007 ; 298: 1772-1778.
9. Dowell SF, Butler JC, Giebink GS Acute otitis media: management and surveillance in an era of pneumococcal resistance. Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Nurse Pract 1999 ; 24 (10 Suppl). 1-9.
10. Performance Standards for Antimicrobial Susceptibility Testing, 16th Informational Supplement. Document M100-S16. Wayne, PA: Clinical Laboratory Standards Institute ; 2006.
11. Aap/Aafp Aom Clinical Practice Guideline. Subcommittee on Management of Acute Otitis Media. Diagnosis and Management of Acute Otitis Media. Pediatrics. 2004 ; 113: 1451-1465.
12. Anon JB, Jacobs MR, Poole MD, et al. The Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2004 ; 130 (1 Suppl). 1-45.
13. Pichichero ME Acute otitis media: part II. Treatment in an era of increasing antibiotic resistance. Am Fam Physician. 2000 ; 61: 2410-2416.
14. Pichichero ME, Reed MD Variations of pharmacokinetic/ pharmacodynamic (PK/PD) parameters of amoxicillin may explain treatment failure in acute otitis media. Pediatr Drugs. 2008. In press.
15. Leibovitz E., Piglansky L., Raiz S., et al. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000 ; 19: 1040-1045.
16. Poehling KA, Lafleur BJ, Szilagyiet PG, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2007 ; 119: 707-715.
17. McEllistrem MC, Adams J., Mason EO, et al. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003 ; 188: 1679-1684.
18. Pelton SI, Loughlin AM, Marchant CD Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J. 2004 ; 23: 1015-1022.
19. Farrell DJ, Klugman KP, Pichichero ME Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J. 2007 ; 26: 123-128.